The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Interleukin-1, inflammasomes, autoinflammation and the skin
Open accessAbstract
Interleukin 1, one of the first cytokines discovered in the 1980s, and a potent mediator of fever, pain and inflammation, is at present experiencing a revival in biology and medicine. Whereas the mechanism of activation and secretion of interleukin 1β, which critically regulates the function of this molecule, has remained mysterious for some 30 years following its discovery, the identification of a new cytoplasmic complex of proteins regulating IL-1β activation and secretion has carried our understanding of the role of IL1 in biology and disease one big step further. The inflammasomes, recently identified innate immune complexes that sense intracellular danger- (e.g. uric acid, ATP, cytoplasmic DNA) or pathogen-associated molecular patterns (e.g. muramyl dipeptide, flagellin, anthrax lethal toxin), are now known to be responsible for triggering inflammation in response to several molecular patterns, including, for example, uric acid, a danger-associated molecular pattern and trigger of gout. Dysregulation of inflammasome function is however also the cause of a family of genetic autoinflammatory diseases known as cryopyrin-associated periodic syndromes (CAPS) characterised by recurrent episodes of fever, urticarial-like skin lesions, systemic inflammation and arthritis. In mouse models recapitulating mutations observed in CAPS, neutrophilic inflammation of the skin is a cardinal feature, in a manner similar to several autoinflammatory diseases with skin involvement such as PAPA (pyoderma gangrenosum, acne and pyogenic arthritis) and Schnitzler's syndrome, in which IL-1β very probably plays a pathogenic role. In this article the role of the inflammasome in IL-1 biology, autoinflammation and disease is reviewed, together with new avenues for the therapy of these diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Duewell, P., Kono, H., Rayner, K. J., Sirois, C. M., Vladimer, G., Bauernfeind, F. G., Abela, G. S., Franchi, L., Nuñez, G., Schnurr, M., et al. (2010) · Nature · doi:10.1038/nature08938 · Cited by 4,026
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Pyroptosis: host cell death and inflammation
Bergsbaken, T., Fink, S. L., & Cookson, B. T. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2070 · Cited by 3,288
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708
The Inflammasomes: Guardians of the Body
Martinon, F., Mayor, A., & Tschopp, J. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132715 · Cited by 2,436
Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis
Shimada, K., Crother, T. R., Karlin, J., Dagvadorj, J., Chiba, N., Chen, S., Ramanujan, V. K., Wolf, A. J., Vergnes, L., Ojcius, D. M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.009 · Cited by 2,282
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?
Tschopp, J., & Schroder, K. (2010) · Nature reviews. Immunology · doi:10.1038/nri2725 · Cited by 1,859
Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., & Tschopp, J. (2004) · Immunity · doi:10.1016/s1074-7613(04)00046-9 · Cited by 1,768
Skin immune sentinels in health and disease
Nestle, F. O., Meglio, P. D., Qin, J., & Nickoloff, B. J. (2009) · Nature reviews. Immunology · doi:10.1038/nri2622 · Cited by 1,529
Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria
Miao, E. A., Leaf, I. A., Treuting, P. M., Mao, D. P., Dors, M., Sarkar, A., Warren, S. E., Wewers, M. D., & Aderem, A. (2010) · Nature Immunology · doi:10.1038/ni.1960 · Cited by 1,336
Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease
Masters, S. L., Simon, A., Aksentijevich, I. A., & Kastner, D. L. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141627 · Cited by 1,083
AN ACUTE FEBRILE NEUTROPHTLIC DERMATOSTS.
SWEET, R. B. (1964) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1964.tb14541.x · Cited by 1,052
An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor Antagonist
Aksentijevich, I. A., Masters, S. L., Ferguson, P. J., Dancey, P., Frenkel, J., van Royen‐Kerkhof, A., Laxer, R. M., Tedgård, U., Cowen, E. W., Pham, T., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807865 · Cited by 981
Sutterwala, F. S., Ogura, Y., Szczepanik, M., Lara-Tejero, M., Lichtenberger, G. S., Grant, E. P., Bertin, J., Coyle, A. J., Galán, J. E., Askenase, P. W., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.02.004 · Cited by 980
Weber, A., Wasiliew, P., & Kracht, M. (2010) · Science Signaling · doi:10.1126/scisignal.3105cm1 · Cited by 962
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
Goldbach‐Mansky, R. T., Garnes, N. D., Canna, S., Gelabert, A., Jones, J. H., Rubin, B. I., Kim, H. J., Brewer, C. C., Zalewski, C. K., Wiggs, E. A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055137 · Cited by 923
T cell– and B cell–independent adaptive immunity mediated by natural killer cells
O’Leary, J. G., Goodarzi, M., Drayton, D. L., & von Andrian, U. H. (2006) · Nature Immunology · doi:10.1038/ni1332 · Cited by 920
IL-1 pathways in inflammation and human diseases
Gabay, C., Lamacchia, C., & Palmer, G. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.4 · Cited by 897
Active Caspase-1 Is a Regulator of Unconventional Protein Secretion
Keller, M., Rüegg, A., Werner, S., & Beer, H. (2008) · Cell · doi:10.1016/j.cell.2007.12.040 · Cited by 851
Self-citationNetea, M. G., Nold‐Petry, C. A., Nold, M. F., Joosten, L. A. B., Opitz, B., van der Meer, J. H. M., van de Veerdonk, F. L., Ferwerda, G., Heinhuis, B., Devesa, I., et al. (2008) · Blood · doi:10.1182/blood-2008-03-146720 · Cited by 787
Interleukin-1, Interleukin-1 Receptors and Interleukin-1 Receptor Antagonist
Dinarello, C. A. (1998) · International Reviews of Immunology · doi:10.3109/08830189809043005 · Cited by 761
Getting under the skin of epidermal morphogenesis
Fuchs, E., & Raghavan, S. (2002) · Nature Reviews Genetics · doi:10.1038/nrg758 · Cited by 753
Aksentijevich, I. A., Nowak, M., Mallah, M., Chae, J. J., Watford, W. T., Hofmann, S. R., Stein, L. D., Russo, R. A. G., Goldsmith, D. P., Dent, P. B., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10688 · Cited by 746
Spectrum of clinical features in Muckle‐Wells syndrome and response to anakinra
Hawkins, P. N., Lachmann, H. J., Aganna, E., & McDermott, M. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20033 · Cited by 743
Mechanisms of regulated unconventional protein secretion
Nickel, W., & Rabouille, C. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2617 · Cited by 726
Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection
Gläser, R., Harder, J., Lange, H., Bartels, J., Christophers, E., & Schröder, J.-M. (2005) · Nature Immunology · doi:10.1038/ni1142 · Cited by 651
The mystery of nonclassical protein secretion
Nickel, W. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03577.x · Cited by 586
Hoffman, H. M., Throne, M. L., Amar, N. J., Sebai, M., Kivitz, A. J., Kavanaugh, A., Weinstein, S. P., Belomestnov, P., Yancopoulos, G. D., Stahl, N., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23687 · Cited by 577
The Inflammasome Mediates UVB-Induced Activation and Secretion of Interleukin-1β by Keratinocytes
Feldmeyer, L., Keller, M., Niklaus, G., Hohl, D., Werner, S., & Beer, H.-D. (2007) · Current Biology · doi:10.1016/j.cub.2007.05.074 · Cited by 544
Self-citationShoham, N. G., Centola, M. B., Mansfield, E. A., Hull, K. M., Wood, G., Wise, C. A., & Kastner, D. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2135380100 · Cited by 497
Cytosolic DNA Triggers Inflammasome Activation in Keratinocytes in Psoriatic Lesions
Dombrowski, Y., Perić, M., Koglin, S., Kammerbauer, C., Göß, C., Anz, D., Simanski, M., Gläser, R., Harder, J., Hornung, V., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002001 · Cited by 440
Activation of the IL-1β-Processing Inflammasome Is Involved in Contact Hypersensitivity
Watanabe, H., Gaide, O., Pétrilli, V., Martinon, F., Contassot, E., Roques, S., Kummer, J. A., Tschopp, J., & French, L. E. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700819 · Cited by 416
Self-citationAn Autoinflammatory Disease Due to Homozygous Deletion of the IL1RN Locus
Reddy, S. T., Jia, S., Geoffrey, R., Lorier, R., Suchi, M., Broeckel, U., Hessner, M. J., & Verbsky, J. W. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0809568 · Cited by 408
NLRs at the intersection of cell death and immunity
Ting, J. P.-Y., Willingham, S. B., & Bergstralh, D. T. (2008) · Nature Reviews Immunology · doi:10.1038/nri2296 · Cited by 371
Meng, G., Zhang, F., Fuss, I. J., Kitani, A., & Strober, W. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.012 · Cited by 365
Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51
Di̇reskeneli̇, H. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.11.996 · Cited by 317
Behçet's disease – a contemporary review
Martins‐Mendes, D., Correia, M., Barbedo, M., Vaio, T. M. R., Mota, M., Gonçalves, O., & Valente, J. P. P. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.02.011 · Cited by 316
Caspase 1–independent activation of interleukin‐1β in neutrophil‐predominant inflammation
Gumá, M., Ronacher, L., Liu‐Bryan, R., Takai, S., Karin, M., & Corr, M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24959 · Cited by 305
Joosten, L. A. B., Netea, M. G., Fantuzzi, G., Koenders, M. I., Helsen, M. M. A., Sparrer, H., Pham, C. T. N., van der Meer, J. W. M., Dinarello, C. A., & van den Berg, W. B. (2009) · Arthritis & Rheumatism · doi:10.1002/art.25006 · Cited by 304
Critical functions of priming and lysosomal damage for NLRP3 activation
Hornung, V., & Latz, E. (2010) · European Journal of Immunology · doi:10.1002/eji.200940185 · Cited by 297
Granzyme B-Dependent Proteolysis Acts as a Switch to Enhance the Proinflammatory Activity of IL-1α
Afonina, I. S., Tynan, G. A., Logue, S. E., Cullen, S. P., Bots, M. L., Lüthi, A. U., Reeves, E. P., McElvaney, N. G., Medema, J. P., Lavelle, E. C., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.07.037 · Cited by 275
Neven, B., Marvillet, I., Terrada, C., Ferster, A., Boddaert, N., Couloignier, V., Pinto, G., Pagnier, A., Bodemer, C., Bodaghi, B., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.25057 · Cited by 264
Mice deficient in IL-1beta manifest impaired contact hypersensitivity to trinitrochlorobenzone.
Shornick, L. P., Togni, P. D., Mariathasan, S., Goellner, J. J., Strauss‐Schoenberger, J., Karr, R. W., Ferguson, T. A., & Chaplin, D. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.4.1427 · Cited by 237
Schindler, R., Gelfand, J., & Dinarello, C. (1990) · Blood · doi:10.1182/blood.v76.8.1631.1631 · Cited by 228
Schindler, R., Clark, B. D., & Dinarello, C. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86936-8 · Cited by 228
Brenner, M., Ruzicka, T., Plewig, G., Thomas, P., & Herzer, P. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09404.x · Cited by 225
Kuemmerle-Deschner, J. B., HACHULLA, E., Cartwright, R. C., Hawkins, P. N., Tran, T.-A., Bader‐Meunier, B., Hoyer, J. D., Gattorno, M., Gül, A., Smith, J. Y. C., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2011.152728 · Cited by 224
The Role of Heat Shock Protein, Microbial and Autoimmune Agents in the Aetiology of Behget's Disease
Lehner, T. (1997) · International Reviews of Immunology · doi:10.3109/08830189709116842 · Cited by 214
Anakinra for flares of pyogenic arthritis in PAPA syndrome
Dierselhuis, M. P. (2005) · British journal of rheumatology · doi:10.1093/rheumatology/keh479 · Cited by 199
Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation
DINARELLO, C. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.03.010 · Cited by 195
Caspase-4 Is Required for Activation of Inflammasomes
Sollberger, G., Strittmatter, G. E., Kistowska, M., French, L. E., & Beer, H. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101620 · Cited by 163
Self-citationInterleukin-1, inflammasomes and the skin
Feldmeyer, L., Werner, S., French, L. E., & Beer, H. (2010) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2010.04.008 · Cited by 154
Self-citationBlocking interleukin-1β in acute and chronic autoinflammatory diseases
Dinarello, C. A. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02313.x · Cited by 146
Dramatic Improvement of Pyoderma Gangrenosum with Infliximab in a Patient with PAPA Syndrome
Stichweh, D., Punaro, M., & Pascual, V. (2005) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2005.22320.x · Cited by 132
Resistant Behçet Disease Responsive to Anakinra
Botsios, C., Sfriso, P., Furlan, A., Punzi, L., & Dinarello, C. A. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-4-200808190-00018 · Cited by 131
Cortis, E., Benedetti, F. D., Insalaco, A., Cioschi, S., Muratori, F., D’Urbano, L. E., & Ugazio, A. G. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2004.08.001 · Cited by 119
Acute febrile neutrophilic dermatosis
Dr., N. L. P., & Levine, C. C. (2004) · Springer eBooks · doi:10.1007/3-540-29668-9_101 · Cited by 119
Kluger, N., Gil-Bistes, D., Guillot, B., & Bessis, D. (2011) · Dermatology · doi:10.1159/000326112 · Cited by 97
Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet’s disease
Bilginer, Y., Ayaz, N. A., & Özen, S. (2009) · Clinical Rheumatology · doi:10.1007/s10067-009-1279-8 · Cited by 95
Interleukin-1 Receptor Antagonist Suppresses Contact Hypersensitivity
Kondo, S., Pastore, S., Fujisawa, H., Shivji, G. M., McKenzie, R. C., Dinarello, C. A., & Sauder, D. N. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12320329 · Cited by 81
Deficiency of Interleukin‐1 Receptor Antagonist Responsive to Anakinra
Schnellbacher, C., Ciocca, G., Menendez, R., Aksentijevich, I. A., Goldbach‐Mansky, R. T., Duarte, A. M., & Rivas‐Chacon, R. (2012) · Pediatric Dermatology · doi:10.1111/j.1525-1470.2012.01725.x · Cited by 76
Goldsmith, D., Hoffman, H. M., O’Shea, J. J., Rosenzweig, S. D., Aksentijevich, I. A., Jones, J., Barron, K. S., Wood, G., Rosenberg, H. F., Russo, R. A. G., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/qnf6-eb65 · Cited by 74
Human keratinocytes express AIM2 and respond to dsDNA with IL-1β secretion
Kopfnagel, V., Wittmann, M., & Werfel, T. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01382.x · Cited by 70
Efficacy of anakinra, an IL1 receptor antagonist, in refractory Sweet syndrome
Delluc, A., Limal, N., Puéchal, X., Francès, C., Pietté, J. C., & Cacoub, P. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.068254 · Cited by 69
Glaser, R. L., & Goldbach‐Mansky, R. T. (2008) · Current Allergy and Asthma Reports · doi:10.1007/s11882-008-0047-1 · Cited by 68
Specific interleukin‐1 gene polymorphisms in Turkish patients with Behçet's disease
Coskun, M., Bacanlı, A., Sallakçı, N., Alpsoy, E., Yavuzer, U., & Yeğin, O. (2005) · Experimental Dermatology · doi:10.1111/j.0906-6705.2005.00253.x · Cited by 63
Loock, J., Lamprecht, P., Timmann, C., Mrowietz, U., Csernok, E., & Gross, W. L. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.066 · Cited by 62
Mutations in the PSTPIP1 gene and aberrant splicing variants in patients with pyoderma gangrenosum
Nesterovitch, A. B., Hoffman, M. D., Simon, M., Petukhov, P. A., Tharp, M. D., & Glant, T. T. (2011) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2011.04137.x · Cited by 54
Molecular regulation of inflammation and cell death
Yeretssian, G., Labbè, K., & Saleh, M. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.015 · Cited by 53
Hacham, M., Argov, S., White, R. M., Segal, S., & Apte, R. N. (2002) · PubMed · Cited by 51
Successful canakinumab treatment identifies IL-1β as a pivotal mediator in Schnitzler syndrome
de Koning, H. D., Schalkwijk, J., van der Meer, J. W. M., & Simon, A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.05.023 · Cited by 50
IL-1 cluster gene polymorphisms in Turkish patients with Behçet’s disease
Özçimen, A. A., Dilek, K., Bingöl, Ü., Sarıcaoğlu, H., Sarandöl, A., Taşkapılıoğlu, Ö., Yurtkuran, M., Yurtkuran, M., & Oral, H. B. (2011) · International Journal of Immunogenetics · doi:10.1111/j.1744-313x.2011.01006.x · Cited by 30
Schindler, R., Gelfand, J., & Dinarello, C. (1990) · Blood · doi:10.1182/blood.v76.8.1631.bloodjournal7681631 · Cited by 17
Asahina, A., Sakurai, N., SUZUKI, Y., & Narushima, K. (2009) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2009.03746.x · Cited by 16
Inflammation: a clinical perspective. The Ciba-Geigy Prize for Research in Animal Health
May, S. A., Lees, P., Higgins, A. J., & Sedgwick, A. D. (1987) · Veterinary Record · doi:10.1136/vr.120.22.514 · Cited by 11
Flagged first, then by citations
Research works printed but not linked: 1
- Review article: Medical intelligence
Cited by
Sorted by citations
Causes of epidermal filaggrin reduction and their role in the pathogenesis of atopic dermatitis
Thyssen, J. P., & Kežić, S. (2014) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.06.014 · Cited by 411
Steroidogenesis in the skin: Implications for local immune functions
Slominski, A., Zbytek, B., Nikolakis, G., Manna, P. R., Skobowiat, C., Zmijewski, M., Li, W., Janjetovic, Z., Postlethwaite, A., Zouboulis, C. C., et al. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.006 · Cited by 369
Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment
Alavi, A., French, L. E., Davis, M. D. P., Brassard, A., & Kirsner, R. S. (2017) · American Journal of Clinical Dermatology · doi:10.1007/s40257-017-0251-7 · Cited by 320
Self-citationPathophysiology of pyoderma gangrenosum (PG): An updated review
Braswell, S. F., Kostopoulos, T. C., & Ortega‐Loayza, A. G. (2015) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2015.06.021 · Cited by 269
Targeting the Redox Balance in Inflammatory Skin Conditions
Wagener, F. A. D. T. G., Carels, C. E. L., & Lundvig, D. M. S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14059126 · Cited by 223
Metadata
- Authors
- Contassot, E., Beer, H.-D., & French, L. E.
- Affiliations
- University Hospital Zurich (CH)
- Venue
- Swiss Medical Weekly
- Publisher
- SMW Supporting Association
- Published
- 2012-05-20
- Volume
- 142
- Issue
- 2122
- Pages
- w13590
- ISSN
- 0036-7672 (ISSN-L)
- 1424-3997
- OpenAlex
- W2094787046
- Cited by
- 130
- References
- 79
- Citations by year
- 2025: 4 · 2024: 7 · 2023: 8 · 2022: 6 · 2021: 8 · 2020: 9 · 2019: 9 · 2018: 12 · 2017: 14 · 2016: 14 · 2015: 13 · 2014: 14 · 2013: 12
- FWCI
- 1.14
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- Locations
- Swiss Medical Weekly (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Hematology › Autoimmune and Inflammatory Disorders Research
- Keywords
- IL-1β, inflammasome, autoinflammatory disease, cryopyrin-associated periodic syndromes, PAPA syndrome, Schnitzler's syndrome, uric acid, IL-1β secretion, innate immunity, gout
- MeSH terms
- Animals, Autoimmune Diseases, Humans, Inflammation, Interleukin-1, Skin, Mice, Cryopyrin-Associated Periodic Syndromes, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
